Search research articles
Contact Us
Filters
Showing results (11-20 of 30) with videos related to
Page
of 3
Sort By:
Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontics
|
March 10, 2000
Enlargement of mandibular canal without hypesthesia caused by extranodal non-Hodgkin's lymphoma: a case report
T Yamada, Y Kitagawa, T Ogasawara, et al.
British Journal of Cancer
|
August 6, 2009
CD26 expression on T cell lines increases SDF-1-alpha-mediated invasion
P A Havre, M Abe, Y Urasaki, et al.
Anticancer Research
|
March 1, 1996
Establishment of a daunorubicin-resistant cell line which shows multi-drug resistance by multifactorial mechanisms
Y Urasaki, T Ueda, A Yoshida, et al.
Leukemia Research
|
March 30, 2000
Effect of PSC 833 on the cytotoxicity and pharmacodynamics of mitoxantrone in multidrug-resistant K562 cells
T Fukushima, T Yamashita, H Takemura, et al.
Cancer Research
|
January 1, 1994
Clinical pharmacology of 1-beta-D-arabinofuranosylcytosine-5'-stearylphosphate, an orally administered long-acting derivative of low-dose 1-beta-D-arabinofuranosylcytosine
T Ueda, K Kamiya, Y Urasaki, et al.
Anticancer Research
|
March 4, 2000
Multidrug resistance due to impaired DNA cleavage in a VP-16-resistant human leukemia cell line
T Fukushima, H Takemura, T Yamashita, et al.
Leukemia Research
|
February 5, 1999
Effect of PSC 833 on the cytotoxicity of idarubicin and idarubicinol in multidrug-resistant K562 cells
T Fukushima, T Yamashita, N Yoshio, et al.
Cancer Research
|
February 24, 2001
Topoisomerase I-mediated cytotoxicity of N-methyl-N'-nitro-N-nitrosoguanidine: trapping of topoisomerase I by the O6-methylguanine
P Pourquier, J L Waltman, Y Urasaki, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
May 13, 2015
Associations between oral complications and days to death in palliative care patients
K Matsuo, R Watanabe, D Kanamori, et al.
Anticancer Research
|
September 1, 1994
Pharmacokinetic and clinical pilot study of high-dose intermittent ubenimex treatment in patients with myelodysplastic syndrome
T Ueda, K Tohyama, Y Wano, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 30) with videos related to
Sort By:
Page
of 3
Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontics
|
March 10, 2000
Enlargement of mandibular canal without hypesthesia caused by extranodal non-Hodgkin's lymphoma: a case report
T Yamada, Y Kitagawa, T Ogasawara, et al.
British Journal of Cancer
|
August 6, 2009
CD26 expression on T cell lines increases SDF-1-alpha-mediated invasion
P A Havre, M Abe, Y Urasaki, et al.
Anticancer Research
|
March 1, 1996
Establishment of a daunorubicin-resistant cell line which shows multi-drug resistance by multifactorial mechanisms
Y Urasaki, T Ueda, A Yoshida, et al.
Leukemia Research
|
March 30, 2000
Effect of PSC 833 on the cytotoxicity and pharmacodynamics of mitoxantrone in multidrug-resistant K562 cells
T Fukushima, T Yamashita, H Takemura, et al.
Cancer Research
|
January 1, 1994
Clinical pharmacology of 1-beta-D-arabinofuranosylcytosine-5'-stearylphosphate, an orally administered long-acting derivative of low-dose 1-beta-D-arabinofuranosylcytosine
T Ueda, K Kamiya, Y Urasaki, et al.
Anticancer Research
|
March 4, 2000
Multidrug resistance due to impaired DNA cleavage in a VP-16-resistant human leukemia cell line
T Fukushima, H Takemura, T Yamashita, et al.
Leukemia Research
|
February 5, 1999
Effect of PSC 833 on the cytotoxicity of idarubicin and idarubicinol in multidrug-resistant K562 cells
T Fukushima, T Yamashita, N Yoshio, et al.
Cancer Research
|
February 24, 2001
Topoisomerase I-mediated cytotoxicity of N-methyl-N'-nitro-N-nitrosoguanidine: trapping of topoisomerase I by the O6-methylguanine
P Pourquier, J L Waltman, Y Urasaki, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
May 13, 2015
Associations between oral complications and days to death in palliative care patients
K Matsuo, R Watanabe, D Kanamori, et al.
Anticancer Research
|
September 1, 1994
Pharmacokinetic and clinical pilot study of high-dose intermittent ubenimex treatment in patients with myelodysplastic syndrome
T Ueda, K Tohyama, Y Wano, et al.
Page
of 3